Abstract
Summary: Introduction: Bariatric and metabolic surgeries are safe and effective methods to treat severe obesity and type 2 diabetes mellitus in morbidly obese patients, resp. Morbidly obese patients have been treated using sleeve gastrectomy (SG) as a single bariatric/metabolic (B/M) procedure since 2003 in other countries and since 2006 in the Czech Republic.
Laparoscopic sleeve gastrectomy (LSG) is an effective and feasible B/M procedure with a low rate of complications. This article concerns the use of SG as a bariatric method.
Method: The main principle of SG is vertical resection of the greater curvature of the stomach. SG is a restrictive method with neurohumoral effects and is usually performed via a laparoscopic minimally invasive approach.
Conclusion: LSG is a safe bariatric procedure with good long-term results in terms of weight loss and improvement of metabolic co-morbidities as well a low rate of complications, which can be managed laparoscopically. SG is currently the most widely used B/M procedure in the Czech Republic and most other countries.